新生學校財團法人新生醫護管理專科學校圖書館 |

Metabolic effects of psychotropic drugs

紀錄類型:	書目-電子資源 : 單行本
正題名/作者:	Metabolic effects of psychotropic drugs/ volume editors, J. Thakore, B.E. Leonard.
其他作者:	Leonard, B. E.
出版者:	Basel :S. Karger, : 2009,
面頁冊數:	1 online resource :ill. (some col.) :
附註:	New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology
標題:	Mental Disorders - drug therapy. -
電子資源:	http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=240013
ISBN:	9783805590020

Metabolic effects of psychotropic drugs
Metabolic effects of psychotropic drugs[electronic resource] /volume editors, J. Thakore, B.E. Leonard. - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Modern trends in pharmacopsychiatry,v.261662-4505 ;. - Modern trends in pharmacopsychiatry ;v. 28..

New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology

Includes bibliographical references and indexes.

Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.

ISBN: 9783805590020Subjects--Topical Terms:

82055
Mental Disorders
--drug therapy.

LC Class. No.: RM315 / .M456 2009

Dewey Class. No.: 615/.788

National Library of Medicine Call No.: W1 / MO168P v.26 2009

Metabolic effects of psychotropic drugs
LDR:02143cmm a2200277 a 4500 001 166022
003 SZ-BaSKA
005 20110603112133.0
006 m d
007 cr cn|||||||||
008 160302s2009 sz a ob 001 0 eng d
020 $a 9783805590020
035 $a 240013
040 $a szbaska
050 0 0 $a RM315 $b .M456 2009
050 4 $a RC483 $b .M6 v. 26
060 1 0 $a W1 $b MO168P v.26 2009
060 1 0 $a QV 77.2 $b M587 2009
082 0 0 $a 615/.788 $2 22
245 0 0 $a Metabolic effects of psychotropic drugs $h [electronic resource] / $c volume editors, J. Thakore, B.E. Leonard.
260 $a Basel : $c 2009 $b S. Karger,
300 $a 1 online resource : $b ill. (some col.)
490 1 $a Modern trends in pharmacopsychiatry, $x 1662-4505 ; $v v.26
500 $a New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology
504 $a Includes bibliographical references and indexes.
520 $a Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.
650 2 2 $a Mental Disorders $x drug therapy. $3 82055
650 1 2 $a Psychotropic Drugs $x metabolism. $3 322441
650 1 2 $a Psychotropic Drugs $x adverse effects. $3 293702
650 0 $a Schizophrenia $x Chemotherapy $x Complications. $3 322440
650 0 $a Metabolic syndrome. $3 120440
650 0 $a Psychotropic drugs $x Side effects. $3 302503
700 1 $a Leonard, B. E. $3 322439
700 1 $a Thakore, Jogin H., $d 1962- $3 322438
830 0 $a Modern trends in pharmacopsychiatry ; $v v. 28. $3 271340
856 4 0 $u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=240013